Relapse risk prediction for children with henoch-schonlein purpura based on GA-SVM

被引:0
|
作者
Liu Y. [1 ]
Wang B. [2 ]
Li R. [1 ]
He S. [1 ]
Xi H. [1 ]
Luo Y. [1 ]
机构
[1] Key Laboratory of Cloud Computing and Intelligent Information Processing of Changzhou City, Jiangsu University of Technology, 1801 Zhongwu Road, Changzhou
[2] Department of Pediatrics, Changzhou No. 2 People's Hospital, 29 Xinglong Road, Changzhou
关键词
Genetic algorithm; Henoch-Schönlein purpura; Prediction of relapse risk; Support vector machine;
D O I
10.7546/ijba.2020.24.2.000608
中图分类号
学科分类号
摘要
The relapse risk prediction for children with Henoch-Schonlein purpura can help pediatricians make an accurate prognosis and offer personalized and appropriate follow-up nursing and relapse control to patients. In this study, we propose a Genetic algorithm-Support vector machine (GA-SVM) learning method combining the support vector machine with the genetic algorithm for parameter optimization to capture the nonlinear mapping from a panel of biomarkers to the relapse risk of HSP children. The GA-SVM prediction model is created by using the dataset of 40 samples in clinical treatment and observation of patients. The inputs of the model consist of 19 biomarkers including gender, age, immunoglobulin M, immunoglobulin G, immunoglobulin A, prothrombin time, etc. The outputs consist of 1 and-1, where 1 indicates high relapse risk and-1 indicates low relapse risk. For comparison, the GS-SVM prediction model based on parameter optimization of grid search is also created. The experimental results show that the GA-SVM prediction model has a high prediction accuracy of 90% and is strong in generalization ability. The GA-SVM model for predicting the relapse risk of HSP children is a promising decision support tool of clinical prognosis, which provides pediatricians with valuable assistance to offer rehabilitation treatment to patients. © 2020 by the authors.
引用
收藏
页码:117 / 130
页数:13
相关论文
共 50 条
  • [41] Henoch-Schonlein purpura
    Saulsbury, Frank T.
    CURRENT OPINION IN RHEUMATOLOGY, 2010, 22 (05) : 598 - 602
  • [42] HENOCH-SCHONLEIN PURPURA
    SIBONY, O
    GAZETTE MEDICALE, 1985, 92 (41): : 63 - 65
  • [43] Henoch-Schonlein purpura
    Mrusek, S
    Krüger, M
    Greiner, P
    Kleinschmidt, M
    Brandis, M
    Ehl, S
    LANCET, 2004, 363 (9415): : 1116 - 1116
  • [44] Determination of Risk Factors in Children Diagnosed With Henoch-Schonlein Purpura
    Demircioglu Kilic, Beltinge
    Kasap Demir, Belde
    ARCHIVES OF RHEUMATOLOGY, 2018, 33 (04) : 395 - 401
  • [45] Bartonella seropositivity in children with Henoch-Schonlein purpura
    Joan L Robinson
    Donald W Spady
    Errol Prasad
    Dorothy McColl
    Harvey Artsob
    BMC Infectious Diseases, 5
  • [46] The changes and significance of serum MIDKINE in Henoch-Schonlein purpura nephritis and Henoch-Schonlein purpura nephritis nephritis in children
    Wu, Y.
    Zhou, P.
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2019, 49 : 144 - 145
  • [47] Scrotal involvement in Henoch-Schonlein purpura in children
    Mintzer, CO
    Nussinovitch, M
    Danziger, Y
    Mimouni, M
    Varsano, I
    SCANDINAVIAN JOURNAL OF UROLOGY AND NEPHROLOGY, 1998, 32 (02): : 138 - 139
  • [48] Henoch-Schonlein purpura in Chinese children and adults
    Lin, SJ
    Huang, JL
    ASIAN PACIFIC JOURNAL OF ALLERGY AND IMMUNOLOGY, 1998, 16 (01): : 21 - 25
  • [49] IgA vasculitis (Henoch-Schonlein purpura) in children
    Sag, Erdal
    Arici, Z. Serap
    Ozen, Seza
    EXPERT OPINION ON ORPHAN DRUGS, 2017, 5 (05): : 405 - 410
  • [50] CLINICAL PROFILE OF HENOCH-SCHONLEIN PURPURA IN CHILDREN
    Krishnan, Deepa Kunju
    Padma, Bindu Krishnan
    JOURNAL OF EVOLUTION OF MEDICAL AND DENTAL SCIENCES-JEMDS, 2018, 7 (22): : 2671 - 2673